
Oxypeucedanin
CAS No. 737-52-0
Oxypeucedanin( —— )
Catalog No. M19055 CAS No. 737-52-0
Oxypeucedanin has novel anticancer effect, mediated via induction of G2-M cell cycle arrest and apoptosis in human prostate carcinoma DU145 cells.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 149 | In Stock |
![]() ![]() |
10MG | 255 | In Stock |
![]() ![]() |
25MG | 431 | In Stock |
![]() ![]() |
50MG | 619 | In Stock |
![]() ![]() |
100MG | 861 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameOxypeucedanin
-
NoteResearch use only, not for human use.
-
Brief DescriptionOxypeucedanin has novel anticancer effect, mediated via induction of G2-M cell cycle arrest and apoptosis in human prostate carcinoma DU145 cells.
-
DescriptionOxypeucedanin has novel anticancer effect, mediated via induction of G2-M cell cycle arrest and apoptosis in human prostate carcinoma DU145 cells. Oxypeucedanin is a kind of open-channel blocker of the hKv1.5 channel and it prolongs the APD; therefore, it is an excellent candidate as an antiarrhythmic drug for atrial fibrillation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorOthers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number737-52-0
-
Formula Weight286.28
-
Molecular FormulaC16H14O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (174.65 mM)
-
SMILESCC1(C(O1)COC2=C3C=CC(=O)OC3=CC4=C2C=CO4)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
LAT1-IN-1
LAT1-IN-1 (BCH) ?significantly inhibit cellular uptake of amino acids and mTOR phosphorylation, which induces the suppression of cancer growth and apoptosis.?
-
Imipramine
Imipramine (Dimipressin) is an orally active Fascin1 inhibitor with antidepressant and antitumor activity.
-
3,4,5-Trihydroxycinn...
3,4,5-Trihydroxycinnamic acid decyl ester, an effective inhibitor of lipid absorption and accumulation, exhibits anti-obesity properties and acts as a pancreatic lipase inhibitor, with an EC50 of approximately 0.9 μM.